Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing ...
Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily ...
Indian pharma is entering its next growth phase as a new segment gains traction. We analyse four companies building this ...
Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its ...
('Cosmos Health' or the 'Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has entered into an agreement for the commercialization of its ...
The arrival of the monsoon season provides a much needed relief from scorching summer heatwaves, but it simultaneously ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Stefany Shaheen is targeting President Donald Trump with her first TV ad of the 2026 election cycle in the race for the 1st ...
Diabetes remains a global health concern. In 2024, the World Health Organization (WHO) reported that the number of people ...
Australia’s growing appetite for GLP-1 injectable weight-loss drugs has turned the country into a billion-dollar market for ...
Introduction Type 2 diabetes mellitus (T2DM) is a well-established independent risk factor for dementia and is associated ...
Objectives This study aims to investigate the knowledge, attitudes and practices (KAP) regarding diabetic nephropathy among patients with diabetes. Design A cross-sectional survey was conducted.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results